T1	Intervention 0 10	Daclizumab
T2	Intervention 110 128	placebo-controlled
T3	Intervention 148 158	Daclizumab
T4	Intervention 305 323	whether daclizumab
T5	Intervention 524 542	placebo-controlled
T6	Intervention 873 919	of daclizumab HYP 150 mg or 300 mg, or placebo
T7	Intervention 1324 1339	receive placebo
T8	Intervention 1345 1362	to daclizumab HYP
T9	Intervention 1379 1396	to daclizumab HYP
T10	Intervention 1547 1563	given daclizumab
T11	Intervention 1719 1730	those given
T12	Intervention 1788 1810	free in the daclizumab
T13	Intervention 1852 1859	than in
T14	Intervention 1958 1969	patients in
T15	Intervention 2139 2163	patient given daclizumab
T16	Intervention 2269 2307	INTERPRETATION Subcutaneous daclizumab
T17	Intervention 2467 2491	potential for daclizumab
